Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis

BACKGROUND: Despite the existence of effective drug treatments, tuberculosis (TB) causes 2 million deaths annually worldwide. Effective treatment is complicated by multidrug-resistant TB (MDR TB) strains that respond only to second-line drugs. We projected the health benefits and cost-effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Resch, Stephen C, Salomon, Joshua A, Murray, Megan, Weinstein, Milton C
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483913/
https://www.ncbi.nlm.nih.gov/pubmed/16796403
http://dx.doi.org/10.1371/journal.pmed.0030241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483913/
https://www.ncbi.nlm.nih.gov/pubmed/16796403
http://dx.doi.org/10.1371/journal.pmed.0030241

Ejemplares similares